MSCs for Prevention of MI-induced HF

Conditions:   Myocardial Infarction, Acute;   Myocardial Infarction First;   Myocardial Infarction, Anterior Wall;   Cardiac Remodeling, Ventricular;   STEMI;   Regenerative Medicine;   Heart Failure Interventions:   Biological: Umbilical Cord-Derived Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs);   Other: Conventional Treatment Sponsors:   Shiraz University of Medical Sciences;   National Institute of Medical Research Development (NIMAD), Iran;   Cell Tech Pharmed Company, Iran Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials